InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Febbo Phillip G., Chief Scientific & Med Officer. Director active across 2 companies, notably Veracyte, INC.. Aggregated, 26 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €1.2m. Activity tracked since 11 June 2021. The latest transaction was disclosed on 2 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Febbo Phillip G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
3,639 股@ US$44.88Common StockSEC:0001649245-26-000009:0
10,405 股@ US$42.8933Common StockSEC:0001649245-26-000009:1
2,705 股@ US$43.6618Common StockSEC:0001649245-26-000009:2
3,730 股@ US$47.800.0055% mcap12.2% 占其流量Common StockSEC:0001649245-26-000007:0
29,603 股0Common StockSEC:0001649245-26-000006:0
6,035 股@ US$36.0112.8% 占其流量Common StockSEC:0001649245-26-000004:0
71,806 股0Common StockSEC:0001649245-26-000002:0
2,955 股@ US$46.169.3% 占其流量Common StockSEC:0001649245-25-000007:0
8,349 股@ US$36.01740.0084% mcap50.0% 占其流量Common StockSEC:0001649245-25-000005:0
2,955 股@ US$30.116.7% 占其流量Common StockSEC:0001384101-25-000116:0
2,955 股@ US$26.746.5% 占其流量Common StockSEC:0001384101-25-000068:0
24,160 股0Common StockSEC:0001384101-25-000044:0
4,467 股@ US$32.864912.7% 占其流量Common StockSEC:0001384101-25-000032:0
30,589 股0Common StockSEC:0001384101-25-000024:0
3,934 股@ US$44.089315.0% 占其流量Common StockSEC:0001384101-24-000186:0
6,738 股@ US$44.1225.6% 占其流量Common StockSEC:0001384101-24-000179:0
39,904 股0Common StockSEC:0001384101-24-000036:0
53,182 股0Common StockSEC:0001384101-23-000155:0
7,556 股0Common StockSEC:0001127602-23-008575:0
3,522 股0Common StockSEC:0001127602-23-006823:0
821 股@ US$217.1923.8% 占其流量Common StockSEC:0001127602-22-025123:0
131 股@ US$363.848.8% 占其流量Common StockSEC:0001127602-22-011725:0
3,029 股0Common StockSEC:0001127602-22-008112:0
2,851 股0Common StockSEC:0001127602-22-006616:0
446 股@ US$408.1431.6% 占其流量Common StockSEC:0001127602-21-028723:0
26 条申报中的 25 条
About Febbo Phillip G.
Febbo Phillip G. is Chief Scientific & Med Officer at Veracyte, INC. and SVP Chief Medical Officer at Illumina, INC. He has 23 filings in total, and across the sampled recent filings between 2021-06-14 and 2026-06-04, sell amounts total EUR 675451, with Retenue fiscale as the modal transaction nature.
